Rakovina Therapeutics Inc. announced the appointment of Julie M. Cherrington, PhD to the company's Board of Directors. Dr. Cherrington has served as President and Chief Executive Officer at several oncology companies, including Arch Oncology, Revitope Oncology, Zenith Epigenetics, and Pathway Therapeutics. In addition, she served as President and Executive Vice President, R&D at Phenomix Corporation.